2169 related articles for article (PubMed ID: 24614609)
1. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
2. Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses.
Paparella D; Semeraro F; Scrascia G; Galeone A; Ammollo CT; Kounakis G; de Luca Tupputi Schinosa L; Semeraro N; Colucci M
Ann Thorac Surg; 2010 Feb; 89(2):421-7. PubMed ID: 20103314
[TBL] [Abstract][Full Text] [Related]
3. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia.
Yamanaka A; Kimura F; Yoshida T; Kita N; Takahashi K; Kushima R; Murakmai T
Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():99-103. PubMed ID: 27543913
[TBL] [Abstract][Full Text] [Related]
5. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
6. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
[TBL] [Abstract][Full Text] [Related]
7. Coagulation and fibrinolysis activation markers in prostatic carcinoma patients.
Geenen RW; Delaere KP; van Wersch JW
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):69-72. PubMed ID: 9056745
[TBL] [Abstract][Full Text] [Related]
8. Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation.
Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Akamatsu N; Kishi Y; Makuuchi M
Clin Transplant; 2005 Dec; 19(6):804-9. PubMed ID: 16313329
[TBL] [Abstract][Full Text] [Related]
9. Extended monitoring of hemostatic activation after varicose vein surgery under general anesthesia.
Hinterhuber G; Böhler K; Kittler H; Quehenberger P
Dermatol Surg; 2006 May; 32(5):632-9. PubMed ID: 16706757
[TBL] [Abstract][Full Text] [Related]
10. [Changes in the activation markers of blood coagulation and fibrinolysis in the neonatal period].
Ries M; Klinge J; Rauch R; Zenker M; Aydin I; Harms D
Klin Padiatr; 1996; 208(6):350-4. PubMed ID: 9064377
[TBL] [Abstract][Full Text] [Related]
11. Correlation between clotting and collagen metabolism markers in rheumatoid arthritis.
Gabazza EC; Osamu T; Yamakami T; Ibata H; Sato T; Sato Y; Shima T
Thromb Haemost; 1994 Feb; 71(2):199-202. PubMed ID: 7514817
[TBL] [Abstract][Full Text] [Related]
12. Hemostasis in newborns of smoking and nonsmoking mothers.
Mercelina-Roumans PE; Ubachs JM; van Wersch JW
Am J Obstet Gynecol; 1997 Mar; 176(3):662-6. PubMed ID: 9077625
[TBL] [Abstract][Full Text] [Related]
13. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
[TBL] [Abstract][Full Text] [Related]
14. Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients.
Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Myśliwiec M
Am J Nephrol; 2004; 24(6):624-9. PubMed ID: 15627717
[TBL] [Abstract][Full Text] [Related]
15. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants.
Urlesberger B; Zobel G; Zenz W; Kuttnig-Haim M; Maurer U; Reiterer F; Riccabona M; Dacar D; Gallisti S; Leschnik B; Muntean W
J Pediatr; 1996 Aug; 129(2):264-8. PubMed ID: 8765625
[TBL] [Abstract][Full Text] [Related]
16. Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator.
Gram J; Munkvad S; Leebeek FW; Kluft C; Jespersen J
Coron Artery Dis; 1993 Apr; 4(4):371-7. PubMed ID: 8261210
[TBL] [Abstract][Full Text] [Related]
17. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
[TBL] [Abstract][Full Text] [Related]
18. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
Ohsato K; Okamoto K
Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
[TBL] [Abstract][Full Text] [Related]
19. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of hemostasis activation markers in acute deep vein thrombosis].
Tajanko E; Galar M; Piszcz J; Kłoczko J
Pol Arch Med Wewn; 2002 Mar; 107(3):237-41. PubMed ID: 12107982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]